How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?

Epilepsy Clinical Trial

— MAPE  

Official title:

How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05741541
• Other study ID #: 2022-A02583-40
• Status: Completed
• Start date: February 24, 2023
• Est. completion date: April 29, 2023

Study information

• Verified date: February 2023
• Source: Hopital Nord Franche-Comte
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observationnal study is to identify the informative and educational needs of epilepsy patients to avoid interrupting the therapeutic pathway.

The main question it aims to answer are :

• Identify the patient's expectations of a nurse specializing in epilepsy in the areas of information, predictive elements of good care and adaptation to their state of health

• Identify under-addressed or misunderstood themes

• Identify patient resources and interventions already in place

• Ensuring better continuity of care

• Improve the knowledge of patients and their relatives about the management of their pathology

After a consultation with the neurologist (as part of their usual follow-up), the participants will be referred to a nurse for a semi-directive, individual interview, lasting 30 minutes and composed of open and closed questions. The announcement of the diagnosis, the quality of life or the factors contributing to the difficulties and their repercussions on a daily basis will be discussed during the interview.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: April 29, 2023
• Est. primary completion date: March 29, 2023
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult epileptic patients, over 18 years old

• Patients with focal or generalized epilepsy

• Patients affiliated or entitled to a social security scheme

• Patients who have received informed information about the study and who have co- signed, with the investigator, a non-objection to participation in the study

• Patients whose diagnosis has been made for at least 6 months

Exclusion Criteria:

• Patients with intellectual disabilities

• Minors

• Untreated patients, in remission

• Patients without affiliation to a social security scheme

• Patients under guardianship or curatorship

Related Conditions & MeSH terms

• Epilepsy

Locations

Country	Name	City	State
France	Hôpital Nord Franche-Comté	Trévenans

Sponsors (1)

Lead Sponsor	Collaborator
Hopital Nord Franche-Comte

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Identify the informative and educational needs of epileptic patients to avoid disrupting the therapeutic course by an interview with an nurse.		At inclusion